A Prospective Randomized Clinical Trial of Vincristine versus Human Intravenous Immunoglobulin for Acute Adjunctive Management of Presumptive Primary Immune-Mediated Thrombocytopenia in Dogs

Background Dogs with immune‐mediated thrombocytopenia (ITP) are at risk of hemorrhage when platelet count is

Saved in:
Bibliographic Details
Published in:Journal of veterinary internal medicine 2013-05, Vol.27 (3), p.536-541
Main Authors: Balog, K., Huang, A.A., Sum, S.O, Moore, G.E., Thompson, C., Scott-Moncrieff, J.C.
Format: Article
Language:English
Subjects:
Animals
Antineoplastic Agents, Phytogenic - therapeutic use
Blood Platelets
Dog Diseases - drug therapy
Dogs
Drug Therapy, Combination
Glucocorticoids - administration & dosage
Glucocorticoids - therapeutic use
Human intravenous immunoglobulin
Humans
Immunoglobulins
Immunoglobulins, Intravenous - therapeutic use
Immunologic Factors - therapeutic use
Platelet recovery time
Purpura
Purpura, Thrombocytopenic, Idiopathic - drug therapy
Purpura, Thrombocytopenic, Idiopathic - veterinary
Thrombocytopenia
Thrombocytopenia
Vincristine
Vincristine
Vincristine - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Dogs with immune‐mediated thrombocytopenia (ITP) are at risk of hemorrhage when platelet count is
ISSN:0891-6640
1939-1676
DOI:10.1111/jvim.12066